(SECARE) Swedencare publ - Ratings and Ratios

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0015988167

SECARE: Nutritional Supplements, Treats, Grooming Products, Pet Supplements, Topical Products

Swedencare AB (publ) stands as a prominent player in the global pet healthcare market, offering a diverse range of products tailored for cats, dogs, and horses. With operations spanning Sweden, the UK, Europe, North America, Asia, and beyond, the companys reach is both extensive and strategic. The product portfolio is organized under several key brands, each addressing specific pet care needs. Healthy Breeds focuses on nutritional supplements and grooming products, while Innovet specializes in therapeutic solutions covering areas like orthopedics and dermatology. Stratford Animal Health provides targeted support for veterinary professionals, enhancing their practice efficiency and patient care. ProDen PlaqueOff emerges as a standout product, offering a comprehensive solution to dental health issues in pets. This includes a powder, dental bones, and bites, all designed to promote oral well-being. Additionally, Rx Vitamins for Pets complements the range, ensuring a holistic approach to animal health. Distribution is seamlessly managed through a network of veterinarians, pet stores, and online platforms, ensuring accessibility and convenience for customers. This multi-channel approach underscores the companys commitment to reaching pet owners wherever they are. Founded in 1993 and headquartered in Malmö, Sweden, Swedencare has established a robust presence. Financially, the companys market cap is approximately 7974.92M SEK, with a current P/E ratio of 128.72, indicating a valuation that reflects market confidence in future growth. The forward P/E of 48.54 suggests expectations of continued expansion and profitability. For investors, these metrics highlight Swedencares potential as a growth-oriented investment. The companys strategic product diversification and effective distribution networks position it favorably in a growing pet care market, aligning with trends that emphasize animal health and well-being.

Additional Sources for SECARE Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

SECARE Stock Overview

Market Cap in USD 708m
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
GiC Sub-Industry Biotechnology
IPO / Inception

SECARE Stock Ratings

Growth 5y 20.5%
Fundamental 16.6%
Dividend 58.8%
Rel. Strength Industry -23.2
Analysts -
Fair Price Momentum 39.71 SEK
Fair Price DCF 34.53 SEK

SECARE Dividends

Dividend Yield 12m 0.47%
Yield on Cost 5y 1.41%
Annual Growth 5y 10.44%
Payout Consistency 100.0%

SECARE Growth Ratios

Growth Correlation 3m -29.7%
Growth Correlation 12m -63.5%
Growth Correlation 5y -3.9%
CAGR 5y 23.01%
CAGR/Max DD 5y 0.27
Sharpe Ratio 12m -0.63
Alpha -34.31
Beta 0.40
Volatility 45.96%
Current Volume 123.2k
Average Volume 20d 236.5k
What is the price of SECARE stocks?
As of February 22, 2025, the stock is trading at SEK 46.08 with a total of 123,226 shares traded.
Over the past week, the price has changed by -1.75%, over one month by -4.32%, over three months by +1.72% and over the past year by -23.76%.
Is Swedencare publ a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Swedencare publ is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 16.62 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SECARE as of February 2025 is 39.71. This means that SECARE is currently overvalued and has a potential downside of -13.82%.
Is SECARE a buy, sell or hold?
Swedencare publ has no consensus analysts rating.
What are the forecast for SECARE stock price target?
According to ValueRays Forecast Model, SECARE Swedencare publ will be worth about 44.6 in February 2026. The stock is currently trading at 46.08. This means that the stock has a potential downside of -3.23%.
Issuer Forecast Upside
Wallstreet Target Price 58.7 27.3%
Analysts Target Price - -
ValueRay Target Price 44.6 -3.2%